Piers SRL
5.3 FTEPiers reported total assets of €1.05m at the end of the 2025 financial year (annual accounts filed with the NBB on 29 Oct 2025), with 5.3 full-time equivalents.
The score of Piers shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -60 % Total assets +9 % Headcount (avg FTE) +4 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Piers's annual accounts
Filed annual accounts
- Year ended 31 Mar 2025filed on 29 Oct 2025
- Year ended 31 Mar 2024filed on 22 Oct 2024
- Year ended 31 Mar 2023filed on 02 Oct 2023
- Year ended 31 Mar 2022filed on 31 Oct 2022
- Year ended 31 Mar 2021filed on 29 Oct 2021
Piers's financial analysis
- Solvency26.7%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Piers
Piers's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0889.047.659
- VAT number
- BE0889047659
- Peppol
- Registered · 0208:0889047659 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 25 Apr 2007
- Registered office
- 8400 Ostend
- Size
- Micro · 5.3 FTE
- Latest accounts
- 2025 · filed on 29 Oct 2025
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Piers (SRL) has been based in Ostend since 2007, active in: retail sale of pharmaceutical products. For 2025, it reports a net loss of 68,430 € and equity of 281,323 €; its revenue is not published. With 5.3 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 26.7%, below the median of its sector (44.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Piers
Companies in the same business, of comparable size and area, outside its group.
- Apotheek Helge van de Vijver Retail sale of pharmaceutical products Bredene · balance sheet 978,870 €
- Farmacie Céline Desmet Retail sale of pharmaceutical products Heuvelland · balance sheet €1.06m
- Pharmacie Des Trois Tilleuls Retail sale of pharmaceutical products Watermael-Boitsfort · balance sheet €1.04m
- W.A. Farma Retail sale of pharmaceutical products Kontich · balance sheet €1.09m
- Ma Ressource Santé Retail sale of pharmaceutical products Woluwe-Saint-Lambert · balance sheet €1.17m
- Medifar Retail sale of pharmaceutical products Meerhout · balance sheet 921,854 €
- Sephabel Retail sale of pharmaceutical products Leuven · balance sheet €1.21m
- Bessemer Apotheek Retail sale of pharmaceutical products Lanaken · balance sheet €1.27m
Frequently asked questions about Piers
What is the revenue of Piers?
Piers files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Piers?
In Belgium, the VAT number is the company number prefixed with BE: BE0889047659 for Piers, if the company is VAT-registered. Its company number (CBE) is 0889.047.659.
Where is the registered office of Piers?
According to the CBE register, the registered office of Piers is in 8400 Ostend.
What is the equity of Piers?
At the close of the 2025 financial year, the equity of Piers amounts to 281,323 €, a solvency of 26.7% of total assets.
How many people work at Piers?
5.3 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Piers?
The register lists 2 active mandates at Piers. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Piers
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →